[HTML] cell.com

[HTML][HTML] Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer cell, 2009 - cell.com
Inappropriate drug delivery, secondary toxicities, and persistent chemo-and
immunoresistance have traditionally compromised treatment response in melanoma. Using …
被引用次数：230 相关文章
[PDF] academia.edu

[PDF][PDF] Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer Cell, 2009 - academia.edu
Inappropriate drug delivery, secondary toxicities and persistent chemo-and immuno-
resistance have traditionally compromised treatment response in melanoma. Using cellular …

[引用][C] Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

D Tormo, A Checińska, D Alonso-Curbelo… - Cancer …, 2009 - produccioncientifica.ucm.es

Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer Cell, 2009 - infona.pl
Inappropriate drug delivery, secondary toxicities, and persistent chemo-and
immunoresistance have traditionally compromised treatment response in melanoma. Using …

Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.

D Tormo, A Checińska, D Alonso-Curbelo… - Cancer Cell, 2009 - europepmc.org
Inappropriate drug delivery, secondary toxicities and persistent chemo-and immuno-
resistance have traditionally compromised treatment response in melanoma. Using cellular …
[HTML] nih.gov

[HTML][HTML] Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer cell, 2009 - ncbi.nlm.nih.gov
Inappropriate drug delivery, secondary toxicities and persistent chemo-and immuno-
resistance have traditionally compromised treatment response in melanoma. Using cellular …
[HTML] sciencedirect.com

[HTML][HTML] Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer Cell, 2009 - Elsevier
Inappropriate drug delivery, secondary toxicities, and persistent chemo-and
immunoresistance have traditionally compromised treatment response in melanoma. Using …

[引用][C] Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

D Tormo, A Chęcińska, D Alonso-Curbelo… - Cancer Cell, 2009 - cir.nii.ac.jp
Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and
Apoptosis in Melanoma Cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[PDF] core.ac.uk

[PDF][PDF] Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

E Riveiro-Falkenbach, TG Calvo, L Larribere, D Megıas… - Cancer Cell, 2009 - core.ac.uk
Inappropriate drug delivery, secondary toxicities, and persistent chemo-and
immunoresistance have traditionally compromised treatment response in melanoma. Using …

Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

D Tormo, A Checińska, D Alonso-Curbelo… - Cancer …, 2009 - pubmed.ncbi.nlm.nih.gov
Inappropriate drug delivery, secondary toxicities, and persistent chemo-and
immunoresistance have traditionally compromised treatment response in melanoma. Using …